Jaguar Animal Health (JAGX)
(Delayed Data from NSDQ)
$0.32 USD
+0.02 (8.46%)
Updated May 3, 2024 04:00 PM ET
After-Market: $0.32 0.00 (0.63%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum D VGM
Brokerage Reports
Jaguar Animal Health, Inc. [JAGX]
Reports for Purchase
Showing records 1 - 20 ( 29 total )
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Termination of Coverage-Research Prioritization
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: Research Department
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
HALT-D Interim Results Positive;Reit Buy; Adjusting PT to $3 From $10
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
A different angle on an old problem - Initiation of coverage
Provider: Edison Investment Research Limited
Analyst: CALLOWAY N
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Loses $15.11 cents per share Is Jaguar an Endangered Species?
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Look for 2H19 Events to Lay Groundwork for Value Creation; Reit Buy With Post-Reverse Stock Split Adjusted $10 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Down 70% Since We Lowered to Neutral, where is the Bottom?
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Mytesi Primed to Advance From Nature to Medicine; Initiating With a Buy Rating and $1 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Jaguar Animal Health, Inc.
Industry: Medical - Drugs
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a Buy rating and $2 price target.
Provider: Rodman & Renshaw, Co.
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Unleashing the Jaguar; Initiating at Buy With $2 Price Target
Provider: H.C. Wainwright & Co., Inc.
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Discontinuation of Research Coverage
Provider: Feltl & Company